Rotavirus vaccination and the risk of intussusception

October 2013
Australian Prescriber;Oct2013, Vol. 36 Issue 5, p167
Academic Journal
The article reports on the risks of intestinal disorder intussusception on first and second doses of rotavirus vaccination. It mentions a study in which intussusceptions were examined using self-controlled case series (SCCS) method which was confirmed by Therapeutic Goods Administration (TGA). It adds that the World Health Organization recommended the use of rotavirus vaccine for infants due to its benefits and rare occurance of intussusceptions.


Related Articles

  • Rotavirus Vaccine Trial in Jamaica. Christie, C. D. C.; Duncan, N. D. // West Indian Medical Journal;Jul2012, Vol. 61 Issue 4, p405 

    Worldwide, rotaviruses have been a significant cause of dehydrating gastroenteritis. This contributed to increased infant morbidity and mortality in Jamaica. We enrolled 1804 Jamaican infants in the international randomized, placebo-controlled, pentavalent (G1, G2, G3, G4 and P1) rotavirus...

  • Also of Note.  // Contemporary Pediatrics;Apr2012, Vol. 29 Issue 4, p16 

    The article reports a study which showed that infants receiving pentavalent rotavirus vaccine (RV5) were not at a higher risk for intussusception, either 1 to 7 days or 1 to 30 days after vaccination, compared to the rates of intussusception in infants aged 4 to 34 weeks receiving other vaccines.

  • Monovalent rotavirus vaccine elevates intussusception risk. FREEDMAN, MARIAN; BURKE, MICHAEL G. // Contemporary Pediatrics;Mar2014, Vol. 31 Issue 3, p18 

    The article reports that the risk of intussusception is greater with monovalent rotavirus vaccine as compared to pentavalent rotavirus vaccine based on data from a 5-year study of infants 4-34 weeks old.

  • Rotavirus Vaccine RIX4414 (Rotariâ„¢) A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries. Plosker, Greg L. // PharmacoEconomics;2011, Vol. 29 Issue 11, p989 

    This article provides an overview of the clinical profile of rotavirus vaccine RIX4414 (Rotarix_) in the prevention of rotavirus gastroenteritis (RVGE) in developing countries, followed by a comprehensive review of pharmacoeconomic analyses with the vaccine in low- and middle-income countries....

  • Intussusception after Rotavirus Vaccination � Spontaneous Reports. Escolano, Sylvie; Farrington, C. Paddy; Hill, Catherine; Tubert-Bitter, Pascale // New England Journal of Medicine;12/1/2011, Vol. 365 Issue 22, p2139 

    The article tackles a case series analysis of spontaneous reports of intussusception worldwide after administration of the rotavirus vaccines RV1, or Rotarix from GlaxoSmithKline Biologicals. The increased risk of intussusception 3 to 7 days after administration of the first dose is tested....

  • Influenza virus vaccines for 2006-2007 northern hemisphere.  // WHO Drug Information;2006, Vol. 20 Issue 3, p196 

    The article focuses on flu vaccines listed by the World Health Organization (WHO) to be distributed in the Northern Hemisphere from 2006 to 2007. The vaccines listed for types of influenza included an A(H1N1) or New Caledonia virus, an A(H3N2) or Wisconsin virus, and a B or Malaysia virus. A...

  • Free rotavirus vaccine will be a one-week rush for some. Castaneda, Reynald // New Zealand Doctor;4/23/2014, p5 

    The article reports on the changes in the immunization schedule wherein the rotavirus vaccine RotaTeq (MSD) will be made available free for infants under 15 weeks in New Zealand beginning July 1, 2014.

  • Full, partial immunization with rotavirus vaccine highly protective.  // Infectious Disease News;Aug2011, Vol. 24 Issue 8, p42 

    The article discusses research on the effectiveness of full or partial immunization with pentavalent rotavirus vaccine, by Mary Allen Staat and colleagues, published in "Pediatrics."

  • On the vaccine front: Good news, mostly.  // Contemporary Pediatrics;Jun2004, Vol. 21 Issue 6, p8 

    Reports on the publication of the "Recommended Childhood and Adolescent Immunization Schedule" in May 2004. Difference of the updated schedule from the prior schedule; Effectiveness of pneumococcal conjugate vaccine; Connection between the rotavirus vaccine and intussusception.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics